EPO Biomarkers Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: E485BC88B81AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of EPO Biomarkers in Global, including the following market information:

Global EPO Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global EPO Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Erythropoietin alfa Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of EPO Biomarkers include Siemens, Thermo Fisher Scientific, Pfizer, Novartis, Johnson & Johnson, Merck, LG Life Sciences India, Amgen and Roche and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the EPO Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global EPO Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global EPO Biomarkers Market Segment Percentages, by Type, 2021 (%)

• Erythropoietin alfa
• Erythropoietin beta
• Erythropoietin zeta
• Erythropoietin theta
• Recombinant human erythropoietin
• Darbepoietin alfa

Global EPO Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global EPO Biomarkers Market Segment Percentages, by Application, 2021 (%)

• Diagnostic centers
• Ambulatory care and surgical centers
• Hospitals

Global EPO Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global EPO Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies EPO Biomarkers revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies EPO Biomarkers revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Siemens
• Thermo Fisher Scientific
• Pfizer
• Novartis
• Johnson & Johnson
• Merck
• LG Life Sciences India
• Amgen
• Roche
• Agilent

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 EPO Biomarkers Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global EPO Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EPO BIOMARKERS OVERALL MARKET SIZE

2.1 Global EPO Biomarkers Market Size: 2021 VS 2028
2.2 Global EPO Biomarkers Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top EPO Biomarkers Players in Global Market
3.2 Top Global EPO Biomarkers Companies Ranked by Revenue
3.3 Global EPO Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 EPO Biomarkers Companies in Global Market, by Revenue in 2021
3.5 Global Companies EPO Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 EPO Biomarkers Players in Global Market
  3.6.1 List of Global Tier 1 EPO Biomarkers Companies
  3.6.2 List of Global Tier 2 and Tier 3 EPO Biomarkers Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global EPO Biomarkers Market Size Markets, 2021 & 2028
  4.1.2 Erythropoietin alfa
  4.1.3 Erythropoietin beta
  4.1.4 Erythropoietin zeta
  4.1.5 Erythropoietin theta
  4.1.6 Recombinant human erythropoietin
  4.1.7 Darbepoietin alfa
4.2 By Type - Global EPO Biomarkers Revenue & Forecasts
  4.2.1 By Type - Global EPO Biomarkers Revenue, 2017-2022
  4.2.2 By Type - Global EPO Biomarkers Revenue, 2023-2028
  4.2.3 By Type - Global EPO Biomarkers Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global EPO Biomarkers Market Size, 2021 & 2028
  5.1.2 Diagnostic centers
  5.1.3 Ambulatory care and surgical centers
  5.1.4 Hospitals
5.2 By Application - Global EPO Biomarkers Revenue & Forecasts
  5.2.1 By Application - Global EPO Biomarkers Revenue, 2017-2022
  5.2.2 By Application - Global EPO Biomarkers Revenue, 2023-2028
  5.2.3 By Application - Global EPO Biomarkers Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global EPO Biomarkers Market Size, 2021 & 2028
6.2 By Region - Global EPO Biomarkers Revenue & Forecasts
  6.2.1 By Region - Global EPO Biomarkers Revenue, 2017-2022
  6.2.2 By Region - Global EPO Biomarkers Revenue, 2023-2028
  6.2.3 By Region - Global EPO Biomarkers Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America EPO Biomarkers Revenue, 2017-2028
  6.3.2 US EPO Biomarkers Market Size, 2017-2028
  6.3.3 Canada EPO Biomarkers Market Size, 2017-2028
  6.3.4 Mexico EPO Biomarkers Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe EPO Biomarkers Revenue, 2017-2028
  6.4.2 Germany EPO Biomarkers Market Size, 2017-2028
  6.4.3 France EPO Biomarkers Market Size, 2017-2028
  6.4.4 U.K. EPO Biomarkers Market Size, 2017-2028
  6.4.5 Italy EPO Biomarkers Market Size, 2017-2028
  6.4.6 Russia EPO Biomarkers Market Size, 2017-2028
  6.4.7 Nordic Countries EPO Biomarkers Market Size, 2017-2028
  6.4.8 Benelux EPO Biomarkers Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia EPO Biomarkers Revenue, 2017-2028
  6.5.2 China EPO Biomarkers Market Size, 2017-2028
  6.5.3 Japan EPO Biomarkers Market Size, 2017-2028
  6.5.4 South Korea EPO Biomarkers Market Size, 2017-2028
  6.5.5 Southeast Asia EPO Biomarkers Market Size, 2017-2028
  6.5.6 India EPO Biomarkers Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America EPO Biomarkers Revenue, 2017-2028
  6.6.2 Brazil EPO Biomarkers Market Size, 2017-2028
  6.6.3 Argentina EPO Biomarkers Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa EPO Biomarkers Revenue, 2017-2028
  6.7.2 Turkey EPO Biomarkers Market Size, 2017-2028
  6.7.3 Israel EPO Biomarkers Market Size, 2017-2028
  6.7.4 Saudi Arabia EPO Biomarkers Market Size, 2017-2028
  6.7.5 UAE EPO Biomarkers Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Siemens
  7.1.1 Siemens Corporate Summary
  7.1.2 Siemens Business Overview
  7.1.3 Siemens EPO Biomarkers Major Product Offerings
  7.1.4 Siemens EPO Biomarkers Revenue in Global Market (2017-2022)
  7.1.5 Siemens Key News
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Corporate Summary
  7.2.2 Thermo Fisher Scientific Business Overview
  7.2.3 Thermo Fisher Scientific EPO Biomarkers Major Product Offerings
  7.2.4 Thermo Fisher Scientific EPO Biomarkers Revenue in Global Market (2017-2022)
  7.2.5 Thermo Fisher Scientific Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer EPO Biomarkers Major Product Offerings
  7.3.4 Pfizer EPO Biomarkers Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis EPO Biomarkers Major Product Offerings
  7.4.4 Novartis EPO Biomarkers Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson EPO Biomarkers Major Product Offerings
  7.5.4 Johnson & Johnson EPO Biomarkers Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck EPO Biomarkers Major Product Offerings
  7.6.4 Merck EPO Biomarkers Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 LG Life Sciences India
  7.7.1 LG Life Sciences India Corporate Summary
  7.7.2 LG Life Sciences India Business Overview
  7.7.3 LG Life Sciences India EPO Biomarkers Major Product Offerings
  7.7.4 LG Life Sciences India EPO Biomarkers Revenue in Global Market (2017-2022)
  7.7.5 LG Life Sciences India Key News
7.8 Amgen
  7.8.1 Amgen Corporate Summary
  7.8.2 Amgen Business Overview
  7.8.3 Amgen EPO Biomarkers Major Product Offerings
  7.8.4 Amgen EPO Biomarkers Revenue in Global Market (2017-2022)
  7.8.5 Amgen Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche EPO Biomarkers Major Product Offerings
  7.9.4 Roche EPO Biomarkers Revenue in Global Market (2017-2022)
  7.9.5 Roche Key News
7.10 Agilent
  7.10.1 Agilent Corporate Summary
  7.10.2 Agilent Business Overview
  7.10.3 Agilent EPO Biomarkers Major Product Offerings
  7.10.4 Agilent EPO Biomarkers Revenue in Global Market (2017-2022)
  7.10.5 Agilent Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. EPO Biomarkers Market Opportunities & Trends in Global Market
Table 2. EPO Biomarkers Market Drivers in Global Market
Table 3. EPO Biomarkers Market Restraints in Global Market
Table 4. Key Players of EPO Biomarkers in Global Market
Table 5. Top EPO Biomarkers Players in Global Market, Ranking by Revenue (2021)
Table 6. Global EPO Biomarkers Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global EPO Biomarkers Revenue Share by Companies, 2017-2022
Table 8. Global Companies EPO Biomarkers Product Type
Table 9. List of Global Tier 1 EPO Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 EPO Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global EPO Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - EPO Biomarkers Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - EPO Biomarkers Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global EPO Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - EPO Biomarkers Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - EPO Biomarkers Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global EPO Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global EPO Biomarkers Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global EPO Biomarkers Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America EPO Biomarkers Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America EPO Biomarkers Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe EPO Biomarkers Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe EPO Biomarkers Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia EPO Biomarkers Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia EPO Biomarkers Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America EPO Biomarkers Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America EPO Biomarkers Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa EPO Biomarkers Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa EPO Biomarkers Revenue, (US$, Mn), 2023-2028
Table 30. Siemens Corporate Summary
Table 31. Siemens EPO Biomarkers Product Offerings
Table 32. Siemens EPO Biomarkers Revenue (US$, Mn), (2017-2022)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific EPO Biomarkers Product Offerings
Table 35. Thermo Fisher Scientific EPO Biomarkers Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer EPO Biomarkers Product Offerings
Table 38. Pfizer EPO Biomarkers Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis EPO Biomarkers Product Offerings
Table 41. Novartis EPO Biomarkers Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson EPO Biomarkers Product Offerings
Table 44. Johnson & Johnson EPO Biomarkers Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck EPO Biomarkers Product Offerings
Table 47. Merck EPO Biomarkers Revenue (US$, Mn), (2017-2022)
Table 48. LG Life Sciences India Corporate Summary
Table 49. LG Life Sciences India EPO Biomarkers Product Offerings
Table 50. LG Life Sciences India EPO Biomarkers Revenue (US$, Mn), (2017-2022)
Table 51. Amgen Corporate Summary
Table 52. Amgen EPO Biomarkers Product Offerings
Table 53. Amgen EPO Biomarkers Revenue (US$, Mn), (2017-2022)
Table 54. Roche Corporate Summary
Table 55. Roche EPO Biomarkers Product Offerings
Table 56. Roche EPO Biomarkers Revenue (US$, Mn), (2017-2022)
Table 57. Agilent Corporate Summary
Table 58. Agilent EPO Biomarkers Product Offerings
Table 59. Agilent EPO Biomarkers Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. EPO Biomarkers Segment by Type in 2021
Figure 2. EPO Biomarkers Segment by Application in 2021
Figure 3. Global EPO Biomarkers Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global EPO Biomarkers Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global EPO Biomarkers Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by EPO Biomarkers Revenue in 2021
Figure 8. By Type - Global EPO Biomarkers Revenue Market Share, 2017-2028
Figure 9. By Application - Global EPO Biomarkers Revenue Market Share, 2017-2028
Figure 10. By Region - Global EPO Biomarkers Revenue Market Share, 2017-2028
Figure 11. By Country - North America EPO Biomarkers Revenue Market Share, 2017-2028
Figure 12. US EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 13. Canada EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe EPO Biomarkers Revenue Market Share, 2017-2028
Figure 16. Germany EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 17. France EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 19. Italy EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 20. Russia EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia EPO Biomarkers Revenue Market Share, 2017-2028
Figure 24. China EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 25. Japan EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 28. India EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America EPO Biomarkers Revenue Market Share, 2017-2028
Figure 30. Brazil EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa EPO Biomarkers Revenue Market Share, 2017-2028
Figure 33. Turkey EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 34. Israel EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 36. UAE EPO Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 37. Siemens EPO Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thermo Fisher Scientific EPO Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer EPO Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis EPO Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson EPO Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck EPO Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. LG Life Sciences India EPO Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amgen EPO Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche EPO Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Agilent EPO Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)